Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07132775 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria revised
    • Secondary endpoints: details revised at 9 of 9 entries
    • Study description expanded, about 4 words
    v3
  2. Lead sponsor: [Redacted] to Shirley Ryan AbilityLabv2 Show 5 more changesShow less
    • Trial status: Withheld to Recruiting
    • Primary and study completion dates: Jul 2027
    • Start date: Jul 23, 2025
    • Study title expanded, about 11 words
    • Collaborators expanded, about 5 words
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to to explore the safety and efficacy of the EXOPULSE Mollii suit, a full-body electrostimulation suit, for individuals with neurological or neuromuscular conditions that cause spasticity, hyperreflexia, and/or pain.
Trial Details
NCT Number NCT07132775
Lead Sponsor Shirley Ryan AbilityLab
Collaborators: Otto Bock Healthcare Products GmbH
Conditions
(from sponsor)		 Multiple Sclerosis, Fibromyalgia, Neurologic Disorder, Neuromuscular Disorders
Related terms Fibromyalgia, Multiple Sclerosis, Nervous System Diseases, Neuromuscular Diseases
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov